Towards personalized tumor markers
Abstract The cancer biomarker discovery pipeline is progressing slowly. The difficulties of finding novel and effective biomarkers for diagnosis and management of cancer patients are well-known. We speculate that it is unlikely to discover new serological biomarkers characterized by high sensitivity...
Enregistré dans:
Auteurs principaux: | Vathany Kulasingam, Ioannis Prassas, Eleftherios P. Diamandis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e17bc80beb4f4e19b16255e97dc4774b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
par: Ugljesa Djuric, et autres
Publié: (2017) -
Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
par: Ruining Gong, et autres
Publié: (2021) -
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups
par: Yan W. Asmann, et autres
Publié: (2021) -
Precision oncology- the future of personalized cancer medicine?
par: Ann M. Bode, et autres
Publié: (2017) -
Panels and models for accurate prediction of tumor mutation burden in tumor samples
par: Elizabeth Martínez-Pérez, et autres
Publié: (2021)